Director, US Achondroplasia HCP Marketing Lead

Location:  San Rafael, California Category: Commercial Operations


Who We Are 

Our Commercial organization leads our global sales and marketing strategies around the world. Our integrated team continues to solidify BioMarin’s commercial presence in the United States and Europe and is rapidly growing in other regions, such as Latin America, the Middle East and Asia-Pacific.     
The US Marketing organization supports this vision through developing and implementing brand strategy that drives growth while supporting the core BioMarin values of patient centricity, innovation, ethics, respect, accountability, and continuous learning. The Director, US Achondroplasia HCP Marketing Lead will be responsible for overarching HCP marketing strategy and execution for Voxzogo, in the U.S.   
This leadership position represents an exciting opportunity to lead a critical growth driver for the US business.  BioMarin is uniquely positioned as the historic and future leader in Achondroplasia. The Director, US Achondroplasia HCP Marketing Lead is responsible for overarching HCP vision, strategy and tactics for the cross-functional brand team for Voxzogo in achondroplasia and lifecycle opportunities in the US. They must be a seasoned leader who can influence without direct reporting relationships across all key stakeholder teams in the US (sales, reimbursement hub, market access, global product strategy, medical affairs, compliance, learning and development, etc.)
Strong results orientation and a sense of urgency to get things done are critical. This professional should be a disciplined individual that embraces innovative approaches, and is comfortable in a nimble and growing commercial organization. The Director, US Achondroplasia HCP Marketing Lead must be creative and adaptable to unique and changing situations, be goal-oriented, know how to set aggressive, achievable targets, and motivate internal cross-functional teams as well as third-party vendors and agencies. A strong passion for supporting patients with Rare Disease and their HCPs through compelling marketing and educational programs is essential.
This position serves as the US HCP Brand Lead for Achondroplasia and will be accountable for:     
  • Defining the regional HCP strategy and overseeing the execution of related initiatives in the US for achondroplasia and additional lifecycle indications.
  • Ensuring the achondroplasia HCP strategic and tactical plan is established and maintained.
  • Lead and execute the US marketing strategy for healthcare professionals to drive growth across the region.
  • Collaborating with key cross-functional stakeholders to ensure input, insight and feedback is represented in strategies and operational plans.
  • Acting as the subject matter expert on Achondroplasia HCP related strategy in the region.
  • Develop US commercial HCP strategies and tactics to support continued Voxzogo growth, competitive readiness, and lifecycle development opportunities.
  • Collaboratively engage with US community stakeholders including healthcare professionals, patient advocacy groups, and patients to ensure integration of their perspectives into all HCP plans.
  • Develop, maintain, and optimize HCP target lists in collaboration with sales.
  • Frequent cross-functional collaboration with multiple internal groups (e.g., compliance, sales, field based clinical support, market access, medical, commercial learning and development, marketing operations, etc.), to set vision and execution plan for HCP branded promotions as well as HCP disease state education.
  • Lead and maintain multi-specialty Medical Expert identification & engagement, HCP speaker development, and conference strategy & management.
  • Lead HCP insight gathering initiatives including leading advisory boards and market research projects.
  • Partner with Digital Community team for optimal planning and execution.
  • Marketing reviewer and approver on the BioMarin Promotional Review Board (PRB) for all HCP materials, both branded and unbranded (DSE).
  • Oversight of advertising agencies and internal graphic designers on the development, execution, and maintenance of HCP branded and unbranded materials.
  • Oversee plans for appropriate rollout and training of HCP resources and materials during POA meetings for live and/or webex training, in collaboration with Commercial Learning and Development team.
  • Identify and plan insight collection initiatives to inform brand strategy (e.g., Advisory Boards and/or Market Research with HCPs and/or patients).
  • Partner closely with Achondroplasia Patient Lead and Achondroplasia Digital Lead for coherent execution of all promotional efforts.
  • Minimum 10+ years of related experience in the biotech/pharmaceutical industry, preferably within Rare Disease.
  • Orphan drug experience required.
  • Experience with strategic and executional marketing required.
  • Industry sales experience beneficial, but not required.
  • Experience working in complex and diffused markets preferred
  • Demonstrated ability to work in a team environment, including cross-functional influence without authority, is critical.
  • Strong facilitation and leadership skills required.
  • Ability to interact with and positively influence all levels of business across multiple departments.
  • Strong analytical skills, solid general business skills and a good understanding of the US pharmaceutical market.
  • Excellent project management, attention to detail and executional experience a must-have
Bachelor's degree required
MBA preferred

Note: This description is not intended to be all-inclusive, or a limitation of the duties of the position. It is intended to describe the general nature of the job that may include other duties as assumed or assigned

Equal Opportunity Employer/Veterans/Disabled

An Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.